Home
About
Overview
Sharing Data
ORCID
Help
History (42)
Testing epidermal growth factor receptor mutations in patients with non-small-cell lung cancer to choose chemotherapy: the other side of the coin.
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
Deacylation Mechanism by SIRT2 Revealed in the 1'-SH-2'-O-Myristoyl Intermediate Structure.
See All 42 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Deacylation Mechanism by SIRT2 Revealed in the 1'-SH-2'-O-Myristoyl Intermediate Structure.
Deacylation Mechanism by SIRT2 Revealed in the 1'-SH-2'-O-Myristoyl Intermediate Structure. Cell Chem Biol. 2017 Mar 16; 24(3):339-345.
View in:
PubMed
subject areas
Acylation
Biocatalysis
Crystallography, X-Ray
Fatty Acids, Monounsaturated
Humans
NAD
Peptides
Protein Structure, Tertiary
Recombinant Proteins
Sirtuin 2
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
authors with profiles
Hening Lin